Cargando…

Real-World Use of Generic Meropenem: Results of an Observational Study

Background: To determine the therapeutic effect and tolerability of meropenem in routine clinical practice, in terms of clinical and microbiological response. Methods: A real-world, observational, descriptive, longitudinal study with daily monitoring of clinical history records was conducted on all...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garnica-Velandia, Santiago, Aristizábal-Ruiz, Luz Adriana, Alvarez-Moreno, Carlos Arturo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827234/ https://www.ncbi.nlm.nih.gov/pubmed/33440602 http://dx.doi.org/10.3390/antibiotics10010062

Ejemplares similares

Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics
por: Yang, Ping, et al.
Publicado: (2021)

521. Comparative In Vitro Activity of Meropenem/Vaborbactam and Meropenem Against a Collection of Real-World Clinical Isolates of Pseudomonas aeruginosa
por: Patel, Twisha S, et al.
Publicado: (2019)

Clinical and economic impact of generic versus brand name meropenem use in an intensive care unit in Colombia
por: Ordóñez, Karen, et al.
Publicado: (2019)

A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide(®)) to the innovator brand in critically ill patients
por: Mer, Mervyn, et al.
Publicado: (2016)

Efficacy of Generic Atorvastatin in a Real-World Setting
por: Manasirisuk, Panisa, et al.
Publicado: (2021)

Effect of Generic vs. Brand-Name Meropenem on Mortality in a Colombian Hospital’s Intensive Care Unit
por: Feinstein, Max, et al.
Publicado: (2017)

Efficacy and safety of a generic rosuvastatin in a real-world setting: prospective, observational clinical study in Lebanese patients
por: Betto, Mohamad, et al.
Publicado: (2017)

2247. Real-world Experience with Meropenem–Vaborbactam (M/V) for Treatment of Carbapenem-Resistant Enterobacteriaceae (CRE) Infections
por: Shields, Ryan K, et al.
Publicado: (2019)

The Efficacy and Safety Profile of Generic Intravenous Levetiracetam in a Real-World Setting
por: Ruangritkul, Preechaya, et al.
Publicado: (2021)

Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)
por: Bressler, Adam M., et al.
Publicado: (2019)

611. Meropenem Dosage Optimization in Critically Ill Patients Based on a Population Pharmacokinetic Approach.
por: Romano-Aguilar, Melissa, et al.
Publicado: (2022)

Real-world Multicenter Analysis of Clinical Outcomes and Safety of Meropenem-Vaborbactam in Patients Treated for Serious Gram-Negative Bacterial Infections
por: Alosaimy, Sara, et al.
Publicado: (2020)

Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa
por: Alosaimy, Sara, et al.
Publicado: (2021)

Real-world Biapenem vs. Meropenem in the treatment of severe community-acquired pneumonia in children: A propensity score matching analysis
por: Tao, Xuemei, et al.
Publicado: (2022)

A Call to Action to Track Generic Drug Quality Using Real-World Data and the FDA’s Sentinel Initiative
por: Brown, Joshua D.
Publicado: (2020)

Curcumin-meropenem synergy in carbapenem resistant Klebsiella pneumoniae curcumin-meropenem synergy
por: Gülen, Dumrul, et al.
Publicado: (2021)

Towards a Generic Tool for Prediction of Meropenem Systemic and Infection-Site Exposure: A Physiologically Based Pharmacokinetic Model for Adult Patients with Pneumonia
por: Thémans, Pauline, et al.
Publicado: (2019)

Definition and Classification of Generic Drugs Across the World
por: Alfonso-Cristancho, Rafael, et al.
Publicado: (2015)

Results of treatment with alemtuzumab in a Spanish cohort of patients with multiple sclerosis in the real world: The RealMS study
por: Eichau, Sara, et al.
Publicado: (2023)

No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19
por: Rogosnitzky, Moshe, et al.
Publicado: (2020)

Benchmark of Generic Shapes for Macrocycles
por: Reyes Romero, Atilio, et al.
Publicado: (2020)

Real-World Clinical Use and Outcomes of Telavancin for the Treatment of Bone and Joint Infections: Results from the Telavancin Observational Use Registry (TOUR™)
por: Sims, Charles R., et al.
Publicado: (2021)

Clinical Experience with Telavancin for the Treatment of Patients with Bacteremia and Endocarditis: Real-World Results from the Telavancin Observational Use Registry (TOUR™)
por: Reilly, Joseph, et al.
Publicado: (2020)

Meropenem: continuous or extended infusion?
por: Frippiat, Frédéric, et al.
Publicado: (2020)

Meropenem: Leucopenia: case report
Publicado: (2021)

Brand-Name Antidepressants Outperform Their Generic Counterparts in Preventing Hospitalization for Depression: The Real-World Evidence from Taiwan
por: Hsu, Chih-Wei, et al.
Publicado: (2020)

Evaluating the Use of Meropenem in Hematologic Patients with Febrile Neutropenia: A Retrospective Observational Single-Cohort Study
por: Stuurman, R.A., et al.
Publicado: (2023)

Correction to “Benchmark of Generic Shapes for Macrocycles”
por: Reyes Romero, Atilio, et al.
Publicado: (2021)

From real-world electronic health record data to real-world results using artificial intelligence
por: Knevel, Rachel, et al.
Publicado: (2023)

Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
por: Liu, Chen-Hua, et al.
Publicado: (2018)

Approval rating and opinion of outpatients and general practitioners toward generic drugs: a questionnaire-based real-world study
por: Mattioli, F, et al.
Publicado: (2017)

Peer Review of “No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19”
por: Hamed, Ahmed Abdeen
Publicado: (2020)

Peer Review of “No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19”
por: Howlett, Susan
Publicado: (2020)

Meropenem-induced hypokalemia and metabolic alkalosis
por: Zaki, Syed Ahmed, et al.
Publicado: (2012)

The Radiostability of Meropenem Trihydrate in Solid State
por: Kilińska, Karolina, et al.
Publicado: (2018)

Impact of meropenem on Klebsiella pneumoniae metabolism
por: Foschi, Claudio, et al.
Publicado: (2018)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Park, Jae-Min, et al.
Publicado: (2021)

Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG
por: Dewilde, Sarah, et al.
Publicado: (2023)

Observational designs for real-world evidence studies
por: Taur, Santosh Ramesh
Publicado: (2022)

Pharmacokinetics of meropenem in children with sepsis undergoing extracorporeal life support: A prospective observational study
por: Wang, Yixue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hdmgfir17g4bflfrchq0s33s7h